Please login to the form below

Not currently logged in
Email:
Password:

Evotec

This page shows the latest Evotec news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Another next-gen diabetes research deal for Novo, Vertex and Australia break deadlock

Daily Brief: Another next-gen diabetes research deal for Novo, Vertex and Australia break deadlock

terms. The Copenhagen-headquartered firm has unveiled a series of deals in its core diabetes and metabolic disease area recently, including a research collaboration with Evotec and the acquistion of a

Latest news

More from news
Approximately 12 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Pharma deals continue to slide Pharma deals continue to slide

    For example, Evotec, the German small molecule development company, is acquiring for $300m the US preclinical development company, Aptuit. ... 400. Aptuit (US). Evotec (DE). Company acquisition. Drug discovery and development to IND submission including

  • Deal Watch December 2016 Deal Watch December 2016

    320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... upfront. And although the upfronts are a modest percentage of the headline figure, ranging from < 1% (BioInvent) to 15%

  • Pharma deals in August 2015 Pharma deals in August 2015

    Acquisition of Priority Review Voucher. 350. Evotec. Sanofi. Beta cell modulating treatments for diabetes. ... Acquisition ‐  company. 300. Aperion Biologics Evotec. Sanofi. To develops mall molecule immuno‐therapies.

  • Deal Watch table for December 2014 Deal Watch table for December 2014

    Company acquisition. 375. Evotec / Sanofi. R&D alliance to progress Sanofi discovery phase compounds to preclinical stage (inc Sanofi discovery facility with 200 scientists).

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    130. Evotec /Janssen. R&D collaboration. Target AD collaboration to identify novel therapies for Alzheimer's.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics